Invesaro

Stocks VRCA Earnings

Earnings

Verrica Pharmaceuticals Inc. (VRCA) earnings

Quarterly results of Verrica Pharmaceuticals Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when VRCA files with the SEC.

Next earnings date

Verrica Pharmaceuticals Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) Verrica Pharmaceuticals Inc. reported revenue of $5.9M (-53.8% on the same quarter a year earlier) and a net loss of $13.2M.

Diluted earnings per share were -$0.62.

Filed with the SEC on August 6, 2026.

Revenue by quarter
Q3 24: -$1.8M -$1.8M Q3 24Q4 24: $344K $344K Q4 24Q1 25: $3.4M $3.4M Q1 25Q2 25: $12.7M $12.7M Q2 25Q3 25: $14.3M $14.3M Q3 25Q4 25: $5.1M $5.1M Q4 25Q1 26: $5M $5M Q1 26Q2 26: $5.9M $5.9M Q2 26
Net income by quarter
Q3 24: -$22.9M -$22.9M Q3 24Q4 24: -$16.2M -$16.2M Q4 24Q1 25: -$9.7M -$9.7M Q1 25Q2 25: $204K $204K Q2 25Q3 25: -$274K -$274K Q3 25Q4 25: -$8.1M -$8.1M Q4 25Q1 26: -$9.7M -$9.7M Q1 26Q2 26: -$13.2M -$13.2M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026$5.9M-53.8%-$13.2M-$0.62
Q1 FY2026March 31, 2026$5M+46.1%-$9.7M-$0.45
Q4 FY2025December 31, 2025$5.1M+1,380.2%-$8.1M-
Q3 FY2025September 30, 2025$14.3M--$274K-$0.03
Q2 FY2025June 30, 2025$12.7M-$204K$0.02
Q1 FY2025March 31, 2025$3.4M--$9.7M-$1.03
Q4 FY2024December 31, 2024$344K--$16.2M-
Q3 FY2024September 30, 2024-$1.8M--$22.9M-$4.88

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Verrica Pharmaceuticals Inc.'s next earnings date?

Verrica Pharmaceuticals Inc. is expected to report around November 13, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Verrica Pharmaceuticals Inc.'s latest quarterly results?

For Q2 FY2026, which ended June 30, 2026, Verrica Pharmaceuticals Inc. reported revenue of $5.9M and a net loss of $13.2M. The figures come from its filing with the SEC.

Is Verrica Pharmaceuticals Inc.'s revenue growing?

Revenue in Q2 FY2026 was $5.9M, down 53.8% from $12.7M in the same quarter a year earlier.

Get an email when VRCA reports

Follow VRCA and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when VRCA files with the SEC.

Source: quarterly figures Verrica Pharmaceuticals Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Verrica Pharmaceuticals Inc.